Response to: “Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time”
Crossref DOI link: https://doi.org/10.1007/s00228-022-03387-y
Published Online: 2022-09-13
Published Print: 2022-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kvitne, Kine Eide
Hole, Kristine
Molden, Espen
Robertsen, Ida
Text and Data Mining valid from 2022-09-13
Version of Record valid from 2022-09-13
Article History
Received: 24 August 2022
Accepted: 7 September 2022
First Online: 13 September 2022
Declarations
:
: The authors declare no competing interests.